phrykt

Amgen Inc (AMGN): who owns it and who trades it

As of Nov 12, 2026, AMGN insiders reported 12 open-market sales worth $26.7M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Esteban Santos (Vice president), with $20.8M. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 12, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Amgen

From the latest filings

Overall: more selling than buying. Insiders and Congress mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns AMGN

3,132 funds and institutions reported AMGN shares worth $161B at the end of Q2 2026, about 83% of the company. The largest holder is BlackRock, Inc. with 9.1%.

Funds and institutions (13F) 83%Everyone else 17%

10 largest owners, by share of the company

BlackRock, Inc.9.1%
Vanguard Capital Management LLC6.5%
State Street Corp5.7%
Capital World Investors5.4%
Invesco Ltd.3.0%
Geode Capital Management, LLC2.9%
Charles Schwab Investment Management Inc2.8%
Vanguard Portfolio Management LLC2.8%
Morgan Stanley2.5%
Wells Fargo & Company1.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.49.36M9.15%$17.9B+5%
Vanguard Capital Management LLC35.25M6.53%$12.8B+1%
State Street Corp30.56M5.66%$11.1BNo change
Capital World Investors29.08M5.39%$10.5B-1%
Invesco Ltd.16.32M3.02%$5.9B+257%
Geode Capital Management, LLC15.70M2.91%$5.7B+2%
Charles Schwab Investment Management Inc15.03M2.79%$5.4B+18%
Vanguard Portfolio Management LLC14.85M2.75%$5.4B+2%
Morgan Stanley13.65M2.53%$4.9B-14%
Wells Fargo & Company7.24M1.34%$2.6B+2%
Primecap Management Co6.76M1.25%$2.4B-24%
Capital Research Global Investors6.27M1.16%$2.3B-10%
Northern Trust Corp6.20M1.15%$2.2B-0%
Norges Bank5.63M1.04%$2B–
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC5.39M1.00%$2B+13%
Bank of America Corp5.06M0.94%$1.8B-1%
Royal Bank of Canada4.33M0.80%$1.6B-3%
Goldman Sachs Group Inc4.13M0.77%$1.5B-2%
T. Rowe Price Associates3.96M0.73%$1.4B+112%
Amundi3.89M0.72%$1.4B+15%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, AMGN insiders reported $0 of open-market purchases and $26.7M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$26.7M
12 trades, 5 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Aug 13, 2026
Filed Aug 13, 2026

Purchases and sales by month

$21.1M$21.1MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 13, 2026Rachna KhoslaVice presidentSale1,252$416.43$521KForm 4
Aug 11, 2026Rachna KhoslaVice presidentSale2,000$412.57$825KForm 4
Aug 6, 2026Derek MillerVice presidentSale2,069$402.54$833KForm 4
Aug 6, 2026Derek MillerVice presidentSale1,821$402.54$733KForm 4
Aug 6, 2026Nancy A. GrygielVice presidentSale1,000$402.16$402KForm 4
Aug 6, 2026Nancy A. GrygielVice presidentSale1,970$402.16$792KForm 4
May 4, 2026Nancy A. GrygielVice presidentSale1,237$323.73$400KForm 4
Feb 26, 2026Esteban SantosVice presidentSale24,291$379.12$9.2MForm 4
Feb 26, 2026Esteban SantosVice presidentSale30,501$379.12$11.6MForm 4
Feb 19, 2026Matthew C. BuschVice presidentSale1,000$375.79$376KForm 4
Nov 20, 2025Nancy A. GrygielVice presidentSale1,639$337.26$553KForm 4
Nov 20, 2025Nancy A. GrygielVice presidentSale1,500$337.26$506KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Esteban SantosEVP, Operations–$20.8MFeb 26, 2026
Nancy A. GrygielSVP & CCO–$2.7MAug 6, 2026
Derek MillerSVP, Human Resources–$1.6MAug 6, 2026
Rachna KhoslaSVP, Business Development–$1.3MAug 13, 2026
Matthew C. BuschVP, Finance & CAO–$376KFeb 19, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

AMGN short interest

Low short interest. 2.3% of AMGN shares are sold short: about 1 share in 43. Over the last 12 reports the number of shares short went up 2%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 12.59M AMGN shares were sold short, 2.3% of the shares outstanding, down 5.9% from the report before. At the average daily volume of 2.53M shares, buying them all back would take about 5.0 trading days (days to cover).

Shares short, % of all shares

2.33%May 15Oct 302.66%

Days to cover

5.0May 15Oct 306.7

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202612.59M2.33%-6%2.53M5.0
Oct 15, 202613.38M2.47%-5%2.69M5.0
Sep 30, 202614.03M2.59%-0%3.42M4.1
Sep 15, 202614.06M2.60%+8%2.85M4.9
Aug 31, 202612.97M2.40%+8%2.31M5.6
Aug 14, 202612.04M2.23%-9%2.77M4.3
Jul 31, 202613.28M2.46%+3%2.58M5.2
Jul 15, 202612.85M2.38%-0%2.02M6.4
Jun 30, 202612.87M2.38%+5%3.27M3.9
Jun 15, 202612.20M2.26%+3%2.97M4.1
May 29, 202611.85M2.20%-4%2.38M5.0
May 15, 202612.29M2.28%-5%2.88M4.3

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded AMGN

Since Nov 16, 2024, 15 members of Congress reported 15 purchases and 17 sales of AMGN. The latest was a sale by David J. Taylor on Nov 3, 2026, reported Nov 12, 2026.

Purchases 15Sales 17

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Nov 3, 2026David J. Taylor (R-OH)Sale$1K–$15KSelfNov 12, 2026Report
Oct 15, 2026Sheldon Whitehouse (D-RI)Sale$15K–$50KSpouseNov 2, 2026Report
Sep 22, 2026David J. Taylor (R-OH)Purchase$1K–$15KSelfOct 1, 2026Report
Aug 26, 2026David J. Taylor (R-OH)Sale$1K–$15KSelfSep 5, 2026Report
Aug 12, 2026Sheldon Whitehouse (D-RI)Partial sale$1K–$15KSpouseSep 2, 2026Report
Jun 5, 2026David J. Taylor (R-OH)Purchase$1K–$15KSelfJun 12, 2026Report
Apr 17, 2026Maria Elvira Salazar (R-FL)Sale$15K–$50KSelfMay 8, 2026Report
Mar 27, 2026Alan Armstrong (R-OK)Sale$15K–$50KSelfJul 21, 2026Report
Mar 24, 2026Maria Elvira Salazar (R-FL)Purchase$15K–$50KSelfApr 21, 2026Report
Feb 26, 2026David J. Taylor (R-OH)Sale$1K–$15KSelfMar 6, 2026Report
Jan 29, 2026David J. Taylor (R-OH)Sale$1K–$15KSelfFeb 2, 2026Report
Jan 16, 2026David J. Taylor (R-OH)Purchase$1K–$15KSelfFeb 2, 2026Report
Dec 3, 2025David J. Taylor (R-OH)Sale$1K–$15KSelfDec 5, 2025Report
Oct 24, 2025Marjorie Greene (GA)Purchase$1K–$15KSelfOct 28, 2025Report
Sep 25, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseOct 22, 2025Report
Sep 11, 2025Marjorie Greene (GA)Purchase$1K–$15KSelfSep 27, 2025Report
Sep 4, 2025Sheldon Whitehouse (D-RI)Sale$1K–$15KSelfOct 3, 2025Report
Jun 24, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report
Jun 6, 2025Cliff Bentz (R-OR)Purchase$1K–$15KSpouseJul 9, 2025Report
May 14, 2025Marjorie Greene (GA)Purchase$1K–$15KSelfMay 19, 2025Report
May 12, 2025Jefferson Shreve (R-IN)Sale$15K–$50KSelfJun 22, 2025Report
May 5, 2025Marjorie Greene (GA)Purchase$1K–$15KSelfMay 6, 2025Report
Apr 16, 2025Jared Moskowitz (D-FL)Purchase$1K–$15KChildMay 9, 2025Report
Apr 16, 2025Jared Moskowitz (D-FL)Purchase$1K–$15KSelfMay 9, 2025Report
Apr 15, 2025Tommy Tuberville (R-AL)Sale$15K–$50KJointMay 15, 2025Report
Apr 11, 2025Jefferson Shreve (R-IN)Purchase$15K–$50KSelfMay 8, 2025Report
Apr 8, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$1K–$15KSelfMay 8, 2025Report
Feb 24, 2025Jefferson Shreve (R-IN)Purchase$15K–$50KSelfMar 9, 2025Report
Feb 11, 2025Daniel Meuser (R-PA)Sale$1K–$15KSpouseAug 20, 2025Report
Jan 6, 2025Emily Randall (D-WA)Sale$1K–$15KSpouseFeb 11, 2025Report
Dec 6, 2024Virginia Foxx (R-NC)Purchase$1K–$15KSelfJan 6, 2025Report
Nov 19, 2024Julia Letlow (R-LA)Sale$1K–$15KSelfJan 13, 2026Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Amgen company events

Amgen filed 11 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership, cyberattack). The latest was on Nov 3, 2026.

  1. Nov 3, 2026ResultsReleased financial results. Filing
  2. Oct 27, 2026LeadershipReported a change among its top officers or directors, or their pay. Filing
  3. Aug 4, 2026ResultsReleased financial results. Filing
  4. Jul 31, 2026CyberattackIn July 2026, Amgen Inc. identified unauthorized activity involving data stored in cloud environments hosted by third-party cloud service providers. Filing
  5. May 20, 2026VoteReported shareholder vote results. Filing
  6. May 19, 2026LeadershipAmgen Inc. publicly announced that Peter H. Griffith will retire from the role of the Company’s Executive Vice President and Chief Financial Officer, effective August 31, 2026. Filing
  7. Apr 30, 2026ResultsReleased financial results. Filing
  8. Apr 22, 2026LeadershipReported a change among its top officers or directors, or their pay. Filing
  9. Feb 19, 2026AgreementSigned an important agreement. Filing
  10. Feb 3, 2026ResultsReleased financial results. Filing
  11. Jan 30, 2026AgreementEnded an important agreement. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

How Amgen makes money

Prolia brought in 12% of Amgen's revenue ($4.4B of $36.8B) in 2025. Repatha was next, at 8%.

By product or service, 2025

Other Products$7.3B · 20%
Prolia$4.4B · 12%
Repatha$3B · 8%
Otezla$2.3B · 6%
Enbrel$2.2B · 6%
Evenity$2.1B · 6%
Xgeva$2.1B · 6%
Tepezza$1.9B · 5%
Product and Service, Other$1.6B · 4%
Blincyto$1.6B · 4%
Nplate$1.5B · 4%
Tezspire$1.5B · 4%

By region, 2025

United States$26.4B · 72%
Outside the US$10.3B · 28%

From Amgen's annual report (10-K) for the year ended Dec 31, 2025, filed Feb 13, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money

Amgen financials

Famous investors that hold AMGN

4 of the 50 well-known investors we track reported holding AMGN in their latest 13F filing. The largest position is Ken Fisher's, worth $713M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Fisher · Fisher Asset ManagementQ3 20261.69M$713M0.2%+6%
Ken Griffin · Citadel AdvisorsQ2 2026703,984$255M0.1%+281%
Israel Englander · Millennium ManagementQ2 202679,344$28.7M0.0%-66%
Ray Dalio · Bridgewater AssociatesQ2 202621,869$7.9M0.0%+48%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Amgen Inc (AMGN) stock

Who owns the most AMGN stock?

The largest reported owner of Amgen Inc (AMGN) is BlackRock, Inc., with 9.1% of the company. In total, 3,132 funds and institutions reported holding AMGN at the end of Q2 2026, together about 83% of the shares. See the largest owners.

Are AMGN insiders buying or selling?

In the last 12 months, AMGN insiders reported no open-market purchases and 12 sales worth $26.7M. The latest trade was on Aug 13, 2026. See every trade.

What is the short interest in AMGN?

As of Oct 30, 2026, 12.59M AMGN shares were sold short, 2.3% of the shares outstanding, down 5.9% from the report before. At the average daily volume of 2.53M shares, buying them all back would take about 5.0 trading days (days to cover). See the history.

Have members of Congress traded AMGN?

Yes. 15 members of Congress reported 15 purchases and 17 sales of AMGN since Nov 16, 2024. The latest was reported on Nov 12, 2026. See the trades.

How does Amgen make money?

Prolia brought in 12% of Amgen's revenue ($4.4B of $36.8B) in 2025. Repatha was next, at 8%. See the full split.

Which famous investors hold AMGN?

4 of the 50 well-known investors we track reported AMGN in their latest 13F filing, including Ken Fisher, Ken Griffin, Israel Englander. The largest position is worth $713M. See all holders.

Executive pay

Amgen's chief executive was paid a total of $24.7M for the year ended Dec 31, 2025, up 1% from $24.4M the year before. In the last 12 months, Amgen's executives and directors bought no stock on the open market and sold $26.7M.

Chief executive, total pay$24.7MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$49.4MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$8.5MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.